Lucentis&reg; using Visudyne&reg; study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration

Lucentis&reg; using Visudyne&reg; study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration

Eric Chen, David M Brown, Tien P Wong, Matthew S Benz, Eric Kegley, Joel Cox, Richard H Fish, Rosa Y KimRetina Consultants of Houston, Texas, USAPurpose: Combination verteporfin photodynamic therapy (vPDT) and antivascular endothelial growth factor (anti-VEGF) therapy may decrease the need for injec...

Full description

Bibliographic Details
Main Authors:	Eric Chen, David M Brown, Tien P Wong, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2010-09-01
Series:	Clinical Ophthalmology
Online Access:	http://www.dovepress.com/lucentisreg-using-visudynereg-study-determining-the-threshold-dose-flu-a5314

Similar Items

Treatment of Radiation Retinopathy with Intravitreal Injection of Ranibizumab (Lucentis®)
by: Horowitz SA, et al.
Published: (2020-02-01)

Is monthly retreatment with intravitreal bevacizumab (Avastin&reg;) necessary in neovascular age-related macular degeneration?
by: Nicola G Ghazi, et al.
Published: (2010-04-01)

Pharmacokinetics of intravitreal bevacizumab (Avastin&reg;) in rabbits
by: Sinapis C, et al.
Published: (2011-05-01)

Verteporfin photodynamic therapy combined with intravitreal ranibizumab in neovascular age-related macular degeneration: 24-month follow-up
by: Rosalia Giustolisi, et al.
Published: (2014-09-01)

Results of Intravitreal Ranibizumab Treatment for Exudative Age-Related Macular Degeneration
by: Umut Karaca, et al.
Published: (2012-01-01)

Asthma patients prefer Respimat&reg; Soft Mist&trade; Inhaler to Turbuhaler&reg;
by: Rick Hodder, et al.
Published: (2009-05-01)

A prospective pilot study comparing combined intravitreal ranibizumab and half-fluence photodynamic therapy with ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration
by: Williams PD, et al.
Published: (2012-09-01)

Developments in administration of growth hormone treatment: focus on Norditropin&reg; Flexpro&reg;
by: Kevin CJ Yuen, et al.
Published: (2011-03-01)

A pilot study on the combination treatment of reduced-fluence photodynamic therapy, intravitreal ranibizumab, intravitreal dexamethasone and oral minocycline for neovascular age-related macular degeneration.
by: Sivaprasad, S, et al.
Published: (2011)

Efficacy of epicutaneous Diractin&reg; (ketoprofen in Transfersome&reg; gel) for the treatment of pain related to eccentric muscle contractions
by: Matthias Rother, et al.
Published: (2009-05-01)

NORMAL FLUENCE PHOTODYNAMIC THERAPY ASSOCIATED WITH LAMELLAR MACULAR HOLES IN EXUDATIVE AGE RELATED MACULAR DEGENERATION
by: Alvaro Rodriguez, et al.
Published: (2014-09-01)

An evaluation of the accuracy of the ORange&reg; (Gen II) by comparing it to the IOLMaster&reg; in the prediction of postoperative refraction
by: Chen M
Published: (2012-03-01)

Intravitreal Aflibercept Therapy in Intravitreal Bevacizumab/Ranibizumab Treatment-resistant Exudative Age-related Macular Degeneration
by: Neslihan Sevimli, et al.
Published: (2023-09-01)

Macular functional changes in patients with neovascular age-related macular degeneration receiving ranibizumab therapy (lucentis)
by: Scorcia G, et al.
Published: (2010-05-01)

Intravitreal aflibercept treatment in eyes with exudative age-related macular degeneration following prior treatment with intravitreal ranibizumab
by: Daniel Sanju Narayan, et al.
Published: (2015-01-01)

Intravitreal lucentis combined laser photocoagulation treatment on macular edema
by: Tan-Wei Wei, et al.
Published: (2013-05-01)

Complete Resolution of a Giant Pigment Epithelial Detachment Secondary to Exudative Age-Related Macular Degeneration after a Single Intravitreal Ranibizumab (Lucentis) Injection: Results Documented by Optical Coherence Tomography
by: Eleni Loukianou, et al.
Published: (2010-12-01)

Failure of Implanon&reg; on antituberculous therapy
by: Babatunde A Gbolade
Published: (2010-09-01)

Combination therapy of low-fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane in choroidal osteoma
by: Rodney J Morris, et al.
Published: (2011-01-01)

One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy
by: Sakurai M, et al.
Published: (2014-01-01)

Central aortic blood pressure and augmentation index: comparison between Vasotens&reg; and SphygmoCor&reg; technology
by: Rogoza AN, et al.
Published: (2012-05-01)

Comparison of efficacy of intravitreal injection of Ranibizumab and Conbercept in the treatment of exudative age-related macular degeneration
by: Zhong-Qing Li, et al.
Published: (2022-04-01)

The effect of vitreomacular adhesion in exudative age-related macular degeneration on the results of ranibizumab intravitreal injection
by: Suzuki H, et al.
Published: (2017-08-01)

Azithromycin in DuraSite&reg; for the treatment of blepharitis
by: Jodi Luchs
Published: (2010-06-01)

Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks
by: Alfredo Pece, et al.
Published: (2010-05-01)

Foveal Exudative Macroaneurysm Treated with Intravitreal Ranibizumab
by: Carlos Menezes, et al.
Published: (2015-06-01)

Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone
by: Jos&eacute; M&ordf; Ruiz-Moreno, et al.
Published: (2008-03-01)

Tiotropium HandiHaler&reg; in the treatment of COPD: A safety review
by: Steven Kesten, et al.
Published: (2009-10-01)

Bevacizumab (Avastin&reg;) for the management of anterior chamber neovascularization and neovascular glaucoma
by: Dimitrios Brouzas, et al.
Published: (2009-11-01)

A study of monofocal intraocular lens (AcrySof &reg;) in mini-monovision (MMV) and premium multifocal implantation of ReSTOR&reg;
by: Ming Chen, et al.
Published: (2009-12-01)

THE MACULAR HOLE AFTER INTRAVITREAL INJECTIONS OF RANIBIZUMAB IN A PATIENT WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION – A CASE STUDY
by: Magdalena Kal, et al.
Published: (2013-11-01)

Efficacy of intravitreal Lucentis injection on major and macular branch retinal vein occlusion
by: Jing Wang, et al.
Published: (2020-07-01)

Comparison of Aflibercept (Eylea®) with Ranibizumab (Lucentis®) in treatment of diabetic macular edema by Optical Coherence Tomography
by: Hossam El din Khalil, et al.
Published: (2022-04-01)

Profile of Xeomin&reg; (incobotulinumtoxinA) for the treatment of blepharospasm
by: Park J, et al.
Published: (2011-06-01)

Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case Report
by: Stacey A. Strong, et al.
Published: (2016-09-01)

Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial
by: Gallemore RP, et al.
Published: (2017-01-01)

Looking beyond Lucentis on the management of macular degeneration.
by: Fletcher, E, et al.
Published: (2008)

Intravitreal Ranibizumab Therapy in Wet Type Macular Degeneration
by: Hüseyin Dündar, et al.
Published: (2014-10-01)

Combination therapy of intravitreal triamcinolone and photodynamic therapy with verteporfin for subfoveal choroidal neovascularization
by: Hussain Nazimul, et al.
Published: (2006-01-01)

Use of Artelon&reg; Cosmetic in soft tissue augmentation in dentistry
by: Ko YK, et al.
Published: (2011-06-01)